Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 6Oropharyngeal Neoplasms 5Mouth Neoplasms 5Carcinoma 5Laryngeal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Ovarian Neoplasms 3Nasopharyngeal Carcinoma 3Lung Neoplasms 3Hypopharyngeal Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Testicular Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Seminoma 2Pancreatic Neoplasms 2Neuroblastoma 2Neoplasm Metastasis 2Ganglioneuroblastoma 2Esophageal Neoplasms 2Colorectal Neoplasms 2Carcinoma, Transitional Cell 2Adenocarcinoma of Lung 2Wilms Tumor 1Vulvar Neoplasms 1Uterine Neoplasms 1Teratoma 1Stomatitis 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1

Interventions

Trastuzumab 3trastuzumab deruxtecan 2sacituzumab govitecan 2pertuzumab 2pembrolizumab 2Magnetic Resonance Spectroscopy 2Goserelin 2Carboplatin 2Biopsy 2Ado-Trastuzumab Emtansine 2zanidatamab 1trastuzumab biosimilar HLX02 1spartalizumab 1pyrotinib 1enfortumab vedotin 1camrelizumab 1bicalutamide 1apatinib 1abiraterone 1Tablets 1Specimen Handling 1Radiation 1Poly(ADP-ribose) Polymerase Inhibitors 1Platinum 1PF-05280014 1Ontruzant 1Ogivri 1Observation 1Maytansine 1Leuprolide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Salivary Gland Neoplasms × Platinum × Clear all
NCT06145308 2026-04-02

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing

Peking Union Medical College

Phase 2 Recruiting
39 enrolled
Head & Neck

Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡